| |
Call Shared Solutions®
1-800-887-8100
support. knowledge. answers.
|
| |
Important Safety Information
- COPAXONE® (glatiramer acetate injection) is indicated for the reduction of the
frequency of relapses in relapsing-remitting multiple sclerosis, including patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis
Important Safety Information About COPAXONE®
- The most common side effects of COPAXONE® are redness, pain, swelling, itching, or
a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These reactions are usually mild and seldom require professional treatment. Be sure to tell your doctor about any side effects
- Some patients report a short-term reaction right after injecting COPAXONE® . This
reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and go away by themselves without further problems
- A permanent indentation under the skin at the injection site may occur, due to a local
destruction of fat tissue. Be sure to follow proper injection technique and inform your
doctor of any skin changes
- After you inject COPAXONE®, call your doctor right away if you develop hives, skin
rash with irritation, dizziness, sweating, chest pain, trouble breathing, severe pain at
the injection site or other uncomfortable changes in your general health. Do not give
yourself any more injections until your doctor tells you to begin again
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/Safety/Medwatch, or call 1-800-FDA-1088.
Reference:
- IMS Health National Prescription Audit, February 2010. Data is proprietary to IMS Health.
- Ford C, Goodman AD, Johnson K, et al. Mult Scler. 2010;16(3):342-350.
- Data on file. Teva Neuroscience, Inc.
COP100005001/100889